A novel pathogenetic concept-antiviral immunity in lupus nephritis.
about
A model for lupus brain diseaseTargeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational ChangesThe nuclear γ-H2AX apoptotic ring: implications for cancers and autoimmune diseases.Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genesLymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritis.Unmet medical needs in lupus nephritis: solutions through evidence-based, personalized medicinePentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus.Toll-like receptor and accessory molecule mRNA expression in humans and mice as well as in murine autoimmunity, transient inflammation, and progressive fibrosisThe TREX1 C-terminal region controls cellular localization through ubiquitination.Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis.Danger control programs cause tissue injury and remodeling.Immunopathology of lupus nephritis.Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.The effect of cell death in the initiation of lupus nephritis.The role of extracellular histone in organ injury.Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology.Four danger response programs determine glomerular and tubulointerstitial kidney pathology: clotting, inflammation, epithelial and mesenchymal healing.Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication.Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis.The pathogenesis of lupus nephritis.Toll-like receptors in lupus nephritis.Glomerular disease: Personalized immunomonitoring in lupus and lupus nephritis.
P2860
Q26824461-EDD6CCCE-FA23-4C46-8BBB-11BDE5BEA0F1Q26999377-33D16D95-12AF-46D9-8677-F62D41139709Q33656349-8DC5A8DE-7DAA-4378-938B-942CE3043809Q34312364-CC771164-0108-4957-9E36-183FBA7C8762Q34535634-5BC9F89C-AFA7-4ECF-80D6-CFB77DED417AQ36088877-9082DF04-46B7-44E7-A270-625662D983CAQ36285240-0A3E4A69-A189-4A9E-8319-D43182B64F8DQ37091783-9FC44235-80D2-4F22-86F6-3779C9B42662Q37213843-85909EA2-C69F-432F-9622-05D7F2C20F73Q37541469-12F75263-8B36-4483-ACB7-0FAA4ACB9819Q38024085-E758AA38-BA76-43DF-AF7B-B8B095921078Q38113929-FB41344C-3EF8-40E5-9692-BDDDE3236086Q38176819-AB3A2380-EC70-404D-84B0-2696D38826E3Q38206875-E9E524F3-D516-4AEE-9372-305915A8A9BFQ38231647-9992B46F-9C6C-49D4-A99B-760F3261B76CQ38679240-9E9147A1-2B0F-47A2-90D1-8BFDAB808FE3Q38692356-985DEB33-D183-4549-BAC5-E9A49C142E59Q39603954-32770368-33D2-41F2-976D-0E8A4181FB64Q41105900-F5E4FEBB-7099-41EB-8FD1-ED46E965BB60Q42228695-8F8DFB94-21F0-4D28-8BB4-C20137279A49Q51868414-DDA6F0D3-96BA-4ABC-9345-931EA7913FE7Q52323268-DE91F30B-A06F-4529-A5EA-324191345CECQ53792914-B218FAA9-D756-4DA1-B568-67EC1E98F345
P2860
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@en
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@nl
type
label
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@en
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@nl
altLabel
A novel pathogenetic concept—antiviral immunity in lupus nephritis
@en
prefLabel
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@en
A novel pathogenetic concept-antiviral immunity in lupus nephritis.
@nl
P2860
P356
P1476
A novel pathogenetic concept-antiviral immunity in lupus nephritis
@en
P2093
Adriana Migliorini
P2860
P2888
P304
P356
10.1038/NRNEPH.2011.197
P407
P577
2012-01-17T00:00:00Z